<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00727402</url>
  </required_header>
  <id_info>
    <org_study_id>K23EY015270-01</org_study_id>
    <nct_id>NCT00727402</nct_id>
  </id_info>
  <brief_title>Longitudinal Evaluation of Silicone Hydrogel (LASH) Study</brief_title>
  <acronym>LASH</acronym>
  <official_title>The Longitudinal Evaluation of Silicone Hydrogel (LASH) Contact Lens Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Eye Institute (NEI)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LASH Contact Lens Study is a prospective longitudinal study of silicone hydrogel (SH)
      contact lens wearers who sleep in their lenses for up to 29 consecutive nights (30 days) of
      continuous wear (CW), with monthly disposal. Up to 207 healthy nearsighted or farsighted
      patients with minimal or no astigmatism and no contraindications to CW lens use will be
      followed for 1 year. The primary outcome measure is the time to development of a corneal
      inflammatory event (CIE) as defined by slit lamp findings and patient symptoms. The main
      exposure of interest is corneal staining. Other key exploratory variables include bacterial
      contamination of study lenses and inflammatory mediators found in the tear film.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Incidence of Corneal Inflammatory Events</measure>
    <time_frame>annual</time_frame>
    <description>Unadjusted cumulative incidence of corneal inflammatory events (CIE)using survival analysis methods. CIE are corneal infiltrates found in an otherwise clear cornea.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">205</enrollment>
  <condition>Corneal Infiltrates</condition>
  <arm_group>
    <arm_group_label>Observational</arm_group_label>
    <description>healthy patients fit into lotrafilcon A contact lenses for continuous wear</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      tear samples contact lenses bacteria isolated from contact lenses
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        study volunteers from academic community willing to wear extended wear contact lenses
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient must be at least 15 years old. Children younger than this may not be
             mature enough for CW, and may have difficulty following the strict instructions
             required for CW or sitting through the exam procedures.

          2. The patient must have clear central corneas and free of any anterior segment
             disorders.

          3. The patient must have a spectacle corrected spherical refractive error between +5.50 D
             and -11.00 D with less than or equal to 1.00 D refractive cylinder. The parameters of
             the Ciba Vision Night and Day Lenses range from +6.00 to -10.00 D, and can correct the
             refractive range of this population. Monovision correction will be allowed only if the
             near eye does not exceed +6.00 D.

          4. The patient must be correctable to 20/25 or better with spectacles. Amblyopia will be
             excluded.

          5. Flat and steep corneal curvatures from SimK readings must be between 39.00 and 48.00
             D. Corneal curvatures outside this range may be indicative of a disease state, and
             patients are not expected to comfortably wear either the 8.4 mm or 8.6 mm base curve
             available in Night and Day.(Dumbleton K 2002)

          6. Can be successfully fit with lotrafilcon A lenses at the enrollment visit.

        Exclusion Criteria:

          1. The patient has worn rigid gas permeable lenses within the last 30 days or PMMA lenses
             within the last 3 months. These lenses can transiently alter the corneal shape and
             influence the fitting of soft lenses.

          2. The patient must not be a current extended wear user of lotrafilcon A lenses.

          3. The patient has an autoimmune disease (except for Hashimoto's Thyroiditis),
             immunocompromising disease, connective tissue disease, atopic dermatitis, insulin
             dependent diabetes, or any other systemic disease that in the investigator's opinion
             will affect ocular health.

          4. The patient is taking chronic systemic medications such as corticosteroids,
             antimetabolites, or non-steroidal anti-inflammatory agents or any other medication
             that in the investigator's opinion will affect ocular physiology.

          5. The patient has any ocular disease or condition such as aphakia, corneal dystrophies,
             corneal edema, external ocular infection, iritis, or had any anterior segment surgery.

          6. The patient is taking any ocular medications.

          7. The patient must have less than or equal to grade 2 on any of the slit lamp
             observations of: upper tarsal papilla, corneal staining, corneal neovascularization,
             conjunctival injection, and lid erythema or scales. Slit lamp findings higher than
             grade 2 bias the patient toward an adverse event and it may be difficult to detect
             true change related to CW.

          8. The patient is pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loretta B Szczotka-Flynn, OD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case Western Reserve University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Szczotka-Flynn L, Lass JH, Sethi A, Debanne S, Benetz BA, Albright M, Gillespie B, Kuo J, Jacobs MR, Rimm A. Risk factors for corneal infiltrative events during continuous wear of silicone hydrogel contact lenses. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5421-30. doi: 10.1167/iovs.10-5456. Epub 2010 Jun 10.</citation>
    <PMID>20538985</PMID>
  </results_reference>
  <results_reference>
    <citation>Szczotka-Flynn LB, Bajaksouzian S, Jacobs MR, Rimm A. Risk factors for contact lens bacterial contamination during continuous wear. Optom Vis Sci. 2009 Nov;86(11):1216-26. doi: 10.1097/OPX.0b013e3181bbca18.</citation>
    <PMID>19786927</PMID>
  </results_reference>
  <results_reference>
    <citation>Szczotka-Flynn L, Benetz BA, Lass J, Albright M, Gillespie B, Kuo J, Fonn D, Sethi A, Rimm A. The association between mucin balls and corneal infiltrative events during extended contact lens wear. Cornea. 2011 May;30(5):535-42. doi: 10.1097/ICO.0b013e3181fb8644.</citation>
    <PMID>21173699</PMID>
  </results_reference>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2008</study_first_submitted>
  <study_first_submitted_qc>July 31, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2008</study_first_posted>
  <results_first_submitted>November 9, 2010</results_first_submitted>
  <results_first_submitted_qc>January 14, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 10, 2011</results_first_posted>
  <last_update_submitted>February 13, 2012</last_update_submitted>
  <last_update_submitted_qc>February 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Case Western Reserve University</investigator_affiliation>
    <investigator_full_name>Loretta Szczotka-Flynn</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Observational</title>
          <description>healthy patients fit into lotrafilcon A contact lenses for continuous wear</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="205"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="116"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="116"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Observational</title>
          <description>healthy patients fit into lotrafilcon A contact lenses for continuous wear</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="205"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.8" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=21 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 21 and 50 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;50 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="205"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cumulative Incidence of Corneal Inflammatory Events</title>
        <description>Unadjusted cumulative incidence of corneal inflammatory events (CIE)using survival analysis methods. CIE are corneal infiltrates found in an otherwise clear cornea.</description>
        <time_frame>annual</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Observational</title>
            <description>healthy patients fit into lotrafilcon A contact lenses for continuous wear</description>
          </group>
        </group_list>
        <measure>
          <title>Cumulative Incidence of Corneal Inflammatory Events</title>
          <description>Unadjusted cumulative incidence of corneal inflammatory events (CIE)using survival analysis methods. CIE are corneal infiltrates found in an otherwise clear cornea.</description>
          <units>annual incidence per 100 subjects</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="205"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="410"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.7" lower_limit="20.1" upper_limit="35.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Observational</title>
          <description>healthy patients fit into lotrafilcon A contact lenses for continuous wear</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="205"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="58" subjects_at_risk="205"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>corneal inflammatory event</sub_title>
                <counts group_id="E1" events="44" subjects_affected="38" subjects_at_risk="205"/>
              </event>
              <event>
                <sub_title>Other non-Corneal Inflammatory Event</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="205"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Loretta Szczotka-Flynn OD, PhD</name_or_title>
      <organization>Case Western Reserve University Dept Ophthalmology &amp; Visual Sciences</organization>
      <phone>216-844-3609</phone>
      <email>loretta.szczotka@uhhospitals.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

